Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

Nature·Jan 23

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the causes, underlying biology, and treatment of cognitive impairment in schizophrenia. Studies are investigating various aspects, including nonpharmacological interventions, new therapies targeting specific brain pathways, and the role of genetics and the gut-brain connection. The impact of cognitive deficits on daily functioning and the overall burden of cognitive impairment in schizophrenia are also being examined.

Full coverage

Evidence-Based Nonpharmacological Interventions in Schizophrenia: Focus on Cognitive Impairment

Psychiatric Times·Jun 19

Emerging non-D2 receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways

Frontiers·Jun 24

Rethinking schizophrenia: insights from genomics and implications for research

Nature·May 21

Cognitive Symptoms of Schizophrenia: What to Know

Everyday Health·Feb 20

Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank

Nature·Apr 10

The gut–brain connection: microbes’ influence on mental health and psychological disorders

Frontiers·Jan 7

Cognitive deficits in schizophrenia interfere with real-world functioning.

Psychology Today·Apr 17

Understanding the burden of cognitive impairment associated with schizophrenia: Results from the international LUCIA study

Cambridge University Press & Assessment·Apr 28

View original report at Nature ↗

Fetching the latest headlines…